Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
10,013
+4
+0% +$455 0.01% 597
2025
Q4
$1.08M Buy
10,009
+187
+2% +$18.9K 0.01% 570
2025
Q3
$920K Buy
9,822
+22
+0.2% +$2.05K 0.01% 635
2025
Q2
$850K Buy
9,800
+175
+2% +$14.6K 0.01% 648
2025
Q1
$742K Sell
9,625
-409
-4% -$37.5K 0.01% 664
2024
Q4
$975K Sell
10,034
-194
-2% -$19.5K 0.01% 589
2024
Q3
$954K Buy
10,228
+311
+3% +$27.2K 0.01% 588
2024
Q2
$801K Buy
+9,917
New +$826K 0.01% 603

Other funds holding ACA

Choreo LLC's ACA Position: Q1 2026 in Review

Choreo LLC increased its Arcosa (ACA) stake by 0.04% in Q1 2026, buying an estimated $455 and bringing the position to 10,013 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #597.

Choreo LLC first reported a position in ACA in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.08M in Q4 2025. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Choreo LLC held 10,013 shares of Arcosa worth $1.06M as of Q1 2026.
  • Choreo LLC bought 4 Arcosa shares in Q1 2026, an estimated $455.
  • Arcosa made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #597 holding.
  • Choreo LLC first reported a position in Arcosa in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's Arcosa position peaked at $1.08M in Q4 2025.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.